A novel peptide‐based chemical fluorescence sensor L (Dansyl‐His‐Pro‐Thr‐Cys‐NH 2 ) was designed and synthesized. This sensor exhibits an “On–Off–On” detection cycle to detect Cu 2+ , Zn 2+ , and S 2− in solution. According to the chelation‐enhanced fluorescence (CHEF) mechanism, when Zn 2+ is present, the fluorescence is significantly enhanced and a blue shift occurs, representing a “Turn‐On” phase of the fluorescence detection mode. Because copper ions (Cu 2+ ) have a paramagnetic quenching sensing mechanism, the fluorescence of L quenches rapidly with the formation of the L ‐Cu system, representing the “Turn‐Off” phase. The subsequent introduction of S 2− to the L ‐Cu system results in the recovery of the L ‐fluorescence, thereby representing the second “Turn‐On” phase. As a peptide molecule, the sensor L has several advantages over other types of sensors, including water solubility, high sensitivity, and good biocompatibility, with a very low detection limit. The detection lines of Zn 2+ and Cu 2+ are 97 nM ( R = 0.993) and 75 nM ( R = 0.995), respectively. Additionally, the sensor does not exhibit any obvious cell toxicity. These results indicate that this peptide chemiluminescent sensor has the potential to be applied in in vivo detection.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: